FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1920034 · Received December 3, 2010

Report

Report Number
2953200-2010-02380
Event Type
Injury
Date Received
December 3, 2010
Date of Event
December 1, 2008
Report Date
November 5, 2010
Manufacturer
MEDTRONIC CARDIOVASCULAR SANTA ROSA
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL, RESULTS: MYOCARDIAL INFARCTION AND REVASCULARIZATION.

Description of Event or Problem · 1

DURING INDEX PROCEDURE, ONE ENDEAVOR SPRINT RX DRUG-ELUTING STENT (3.00 X 24MM) WAS IMPLANTED TO THE PROXIMAL LAD. PT HAD CARDIAC STATUS OF STABLE ANGINA AT 30 DAY FOLLOW-UP. ON DAY OF 6 MONTH FOLLOW-UP, PT WAS ADMITTED FOR REPEAT DIAGNOSTIC ANGIOGRAM FOR ONGOING ANGINA SYMPTOMS. ON SAME DAY, A REVASCULARIZATION OF PROXIMAL LAD WAS PERFORMED. THERE WAS AN OTHER BRAND STENT IMPLANTED IN THE PROXIMAL LAD. INVESTIGATOR CLASSIFIED LESION AS RESTENOSIS OF TARGET LESION AFTER PREVIOUS PTCA. INVESTIGATOR STATED THAT EVENT WAS RELATED TO STUDY STENT AND STUDY PROCEDURE. PT HAD CARDIAC STATUS OF STABLE ANGINA AT 1 YEAR AND 1.5 YEAR FOLLOW-UP'S. AT 2 YEAR FOLLOW UP, PT WAS ASYMPTOMATIC / FREE OF SYMPTOMS. IT WAS REPORTED THAT THE PT SUFFERED AN MI APPROXIMATELY 29 MONTHS POST INDEX PROCEDURE. A CABG REVASCULARIZATION AT THE PROXIMAL LAD, RIGHT POSTERIOR DESCENDING ARTERY AND THE 1ST OBTUSE MARGINAL IS ALSO REPORTED TO HAVE OCCURRED APPROXIMATELY 29 MONTHS POST INDEX PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR SANTA ROSA NA 0000506867

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention